IMPROVING KNOWLEDGE, EVALUATING OPINIONS, AND ASCERTAINING THEACCEPTANCE OF GENETIC COUNSELING FOR BIPOLAR DISORDER:ANALYSIS OF RESPONSES IN THE UNITED STATES AND INDIA. by Frace, Stefanie J
 IMPROVING KNOWLEDGE, EVALUATING OPINIONS, AND ASCERTAINING THE 
ACCEPTANCE OF GENETIC COUNSELING FOR BIPOLAR DISORDER: 
ANALYSIS OF RESPONSES IN THE UNITED STATES AND INDIA 
 
 
 
 
 
 
by 
Stefanie J. Frace 
B.S., Cedar Crest College, 2007 
 
 
 
 
 
 
 
 
 
 
Submitted to the Graduate Faculty of 
the Graduate School of Public Health in partial fulfillment  
of the requirements for the degree of 
Master of Science 
 
 
 
 
 
 
 
 
 
University of Pittsburgh 
2009 
 
UNIVERSITY OF PITTSBURGH 
GRADUATE SCHOOL OF PUBLIC HEALTH 
 
 
 
This thesis was presented 
 
by 
 
Stefanie J. Frace 
 
 
 
It was defended on 
March 17, 2009 
and approved by  
Robin E. Grubs, PhD, CGC  
Assistant Professor  
Department of Human Genetics  
Co-Director, Genetic Counseling Program  
Graduate School of Public Health  
University of Pittsburgh  
 
Vishwajit Nimgaonkar, MD, PhD  
Professor  
Department of Human Genetics  
Graduate School of Public Health  
Professor, Department of Psychiatry  
School of Medicine  
University of Pittsburgh  
 
Thesis Advisor:  
Elizabeth Gettig, MS, CGC  
Associate Professor  
Department of Human Genetics  
Co-Director, Genetic Counseling Program  
Graduate School of Public Health  
University of Pittsburgh  
  ii
Copyright © by Stefanie J. Frace 
2009 
  iii
IMPROVING KNOWLEDGE, EVALUATING OPINIONS, AND ASCERTAINING 
THE ACCEPTANCE OF GENETIC COUNSELING FOR BIPOLAR DISORDER: 
ANALYSIS OF RESPONSES IN THE UNITED STATES AND INDIA. 
 
Stefanie J. Frace, M.S. 
University of Pittsburgh, 2009
 
Bipolar disorder (BPD) is a serious mood disorder that affects about 1% of the population of the 
United States.  Twin, family, and adoption studies have shown evidence for a genetic component 
of BPD, but monozygotic twin concordance is less than one, indicating that BPD is a multi-
factorial disorder.  First-degree relatives of an individual with BPD have approximately a 5-30% 
risk of developing BPD because of shared genes and environment.  No strong susceptibility loci 
for BPD have been located, although some areas of interest are currently being evaluated.  With 
increasing genetic information, demand for genetic counseling for BPD and other psychiatric 
disorders are increasing. 
This study used anonymous surveys for individuals with BPD and their first-degree 
relatives to assess knowledge, opinions, and acceptance of genetic counseling. The Health Belief 
Model was used to assess current health beliefs relating to BPD.  Additionally, using a brief 
educational session, the effect of education on knowledge and health beliefs was assessed. 
A similar study was conducted by Dr. Triptish Bhatia in India and she has provided her 
unpublished results so that they could be included in this document for comparative purposes. 
Data show that the perceived severity of BPD and perceived barriers of testing were high 
in both populations. Data show that the perceived susceptibility, benefit, and knowledge of BPD 
in affected individuals were higher in the US population than in the Indian population. 
  iv
Ascertainment criteria and the evaluation procedures for the samples were different in both 
countries and they cannot be considered to be representative of the respective ‘populations’. The 
public health significance includes: the creation of public health programs in which clients can 
learn more about their condition, how BPD is related to genomics and what the risk is to their 
offspring. 
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1.0  INTRODUCTION 
The project was created to determine the current health beliefs of individuals 
diagnosed with Bipolar Disorder (BPD), the current health beliefs of their first-degree 
relatives in response to disease course, treatment, and genetic information, and 
knowledge of BPD. Researchers anticipate that the demand for genetic counseling 
services for psychiatric disorders will increase in the future, on the basis of a lack of 
knowledge among individuals diagnosed with BPD.  
A modified Health Belief model (HBM) was implemented to assess quantitative 
variables in the data set.  The survey was designed to measure familiarity with, and 
interest in, genetic counseling, knowledge of bipolar disorder, and health beliefs. A five-
point scale response system assessed perceived susceptibility, perceived seriousness, 
perceived benefit of testing, and perceived barriers to testing for BPD.  
The Master’s Thesis project was originally designed for fifty or more participants 
in each country. To date, 62 participants have completed the survey and 6 have 
completed the education session and follow-up survey. The data has been analyzed and 
interpreted to this point (April 2009), and it is expected interpretations of the data may be 
higher with more participants added.  
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A final set of questions, five open-ended questions encouraging a discussion of 
the causes of bipolar disorder and the likelihood that there is a genetic component were 
analyzed looking for similar responses. These open-ended questions were analyzed to 
find themes and differences in responses to the questions. 
1.1 SPECIFIC AIM 1 
Knowledge of Bipolar Disorder and the Health Belief Model: 
Specific Aim: To determine the current health beliefs of individuals diagnosed with 
Bipolar Disorder (BPD), the current health beliefs of their first-degree relatives in 
response to disease course, treatment, and genetic information, and knowledge of BPD. 
 
Hypothesis: Participants in a voluntary survey will have a high level of perceived 
severity of BPD, a low level of knowledge about cause of mental illness, a low level of 
perceived susceptibility, a moderate level of perceived benefit to testing, and a low level 
of perceived barriers to testing. The perceived susceptibility, benefit, and knowledge of 
BPD will be higher in the US population than in the Indian population. 
 
Plan: Utilizing anonymous surveys among individuals diagnosed with BPD, and their 
first-degree relatives, the following topics were analyzed: the current state of knowledge 
of disease cause, course, treatment, and genetic information. Assessment of knowledge of 
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psychiatric genetic risks was studied to determine if there is a correlation among health 
beliefs of the disorder. 
 
1.2 SPECIFIC AIM 2 
Knowledge of Bipolar Disorder and Acceptance of Genetic Testing and Counseling: 
Specific Aim: To assess patient’s knowledge of genetic counseling, and to assess 
acceptance of and interest in genetic counseling services and genetic testing. 
 
Hypothesis: US and Indian data will show that the perceived severity of BPD and 
perceived barriers of testing will be high in both populations.  
 
Plan: Utilizing anonymous surveys in individuals diagnosed with BPD and their first-
degree relatives, the current state of knowledge of genetic testing and genetic counseling, 
and acceptance of genetic counseling services were ascertained.  
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2.0  BACKGROUND AND SIGNIFICANCE 
The overall goal of this project was to learn more about the needs of the populations 
diagnosed with BPD, anticipating that the demand for genetic counseling services for 
psychiatric disorders will increase in the future. In order to address these issues, it was 
necessary to review the incidence and natural history of BPD, the current treatment and 
molecular genetics of psychiatric conditions, and published studies that have examined 
opinions of the BPD population to date. An extensive literature review of BPD is 
referenced in E. James’ thesis (2007)1.  
 
2.1 BIPOLAR DISORDER (BPD) EPIDEMIOLOGY 
2.1.1 Incidence and Prevalence of BPD 
Approximately one percent of the US population will be diagnosed with bipolar disorder 
in their lifetime. The average age-at-onset of BPD ranges from 18 years in the United 
States to 27 years in Puerto Rico. While the first symptoms of BPD can appear at almost 
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any age, there appears to be a peak period of onset between 15 and 19 years of age in the 
United States and affects men and women equally2.  
Earlier age of onset indicate increased risk for relatives. 3 Risk to first-degree 
relatives to develop BPD is between 5% and 30%3. Bipolar I disorder, bipolar II disorder, 
and bipolar disorder not otherwise specified are discussed as separate diagnoses only 
when the distinction is clear; in this document, bipolar disorder or BPD includes the 
entire bipolar disorder spectrum, with no distinction made between subtypes.  
2.1.2 Natural History of BPD 
Bipolar disorder, or manic depression, is a condition that causes extreme shifts in mood, 
energy, and functioning. These changes may be subtle or dramatic and typically vary 
greatly over the course of a person’s life as well as among individuals. Over 10 million 
people in America have bipolar disorder, and the condition affects men and women 
equally.4  
Symptoms of mania and depression constitute a diagnosis of BPD. Mania is 
described as one phase of BPD and includes symptoms of: elated or happy mood, 
increased physical and mental energy, racing thoughts, flight of ideas and grandiose 
plans, impulsive activity (spending, alcohol or drug use) or decreased sleep. Depression 
is described as a second phase of BPD. Symptoms of depression include: loss of energy, 
prolonged sadness, inability to concentrate, loss of interest or enjoyment in activities that 
are normally enjoyable, feeling of guilt or thoughts of suicide.  
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Sometimes, individuals may experience an increased frequency of episodes. 
When four or more episodes of illness occur within a year’s time, the individual is said to 
have BPD with rapid cycling. Rapid cycling is more commonly associated in women than 
men because of hormone fluctuation. 
The exact cause of BPD is not known, although most scientists believe that it is a 
collection of multiple factors that lead to a chemical imbalance in the brain. Those factors 
may encompass life events in combination with genetic factors, or each by itself. BPD 
often runs in families and research studies are currently assessing genetic loci involved.  
2.1.3 Treatment of BPD 
Treatment of BPD has been established and published in the Expert Consensus 
Guidelines in 2000. Use of a mood stabilizer is recommended in all phases of treatment. 
Divalproex (DEPAKOTE®) and lithium are the primary mood stabilizers for both acute 
and preventive treatment of mania. If monotherapy fails, the next recommended 
intervention is to combine them. The combination of lithium and divalproex can then 
serve as the foundation to which other medications are added if needed. Carbamazepine 
is the leading alternative mood stabilizer for mania in individuals who are unable to take 
lithium or divalproex5-7.  
Additional medications may be indicated during depressive episodes. 
Antidepressants including, bupropion (Wellbutrin and Zyban), serotonin reuptake 
inhibitors (SSRIs), and venlafaxine (Effexor®) are preferred treatments for mild to severe 
depression. Antidepressants should be tapered 2-6 months after remission of depressive 
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symptoms. New mood stabilizers have been approved by the Food and Drug 
Administration for the treatment and prevention of BPD, including but not limited to, 
Abilify, Celexa, Lamictal and Seroquel4; 5. 
Unfortunately, current treatments are not effective in all individuals with BPD. 
Often, multiple combinations of mood stabilizers are necessary to find the right balance 
for the change of emotions seen in individuals with BPD.  Side effects of mood 
stabilizers may include nausea, weight gain, increased thirst and urination, drowsiness, 
unpleasant or metallic taste in mouth or changes in thyroid or kidney function.  
Electroconvulsive therapy (ECT) is a non-drug treatment for bipolar disorder and 
other mental disorders, such as severe depression. ECT can be beneficial for patients who 
need immediate stabilization of their condition and who cannot wait for medications to 
work. Individuals who benefit for ECT include: most patients with mania -- especially 
elderly patients with severe mania, patients who suffer suicidal thoughts and guilt during 
the depressive phase, patients who cannot tolerate drug treatments, patients with certain 
types of heart problems, and young patients8. In a review of studies, about 80% of ECT-
treated patients experienced improvement, and for some, it is the only treatment that 
works. ECT may help by causing changes in the brain's physiology. For example, ECT 
may increase the permeability of the blood-brain barrier, produce an antiseizure effect 
(similar to the effects of antiseizure drugs used as mood stabilizers), and reduce blood 
flow in parts of the brain associated with improved mood. It also causes various 
hormonal changes, particularly with thyroid-related hormones. ECT has been found to 
balance dopamine levels. This brain chemical plays an important role in bipolar disorder 
as well as other conditions for which ECT is sometimes recommended, including 
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delusional depression. Lastly, ECT can stimulate growth of neurons in the hippocampus 
(the area in the brain responsible for memory) 7; 9; 10. 
2.1.4 Risk Factors for BPD 
A risk factor is a variable associated with an increased chance of disease. Aside from 
genetic susceptibility, gender and age increase an individuals’ risk for BPD. Bipolar 
disorder affects both sexes equally, but there is a higher incidence of rapid cycling, mixed 
states, and cyclothymia in women. On the other hand, early-onset bipolar disorder tends 
to occur more frequently in men and it is associated with a more severe condition. Manic 
phases usually begin in adolescence or young adulthood, with an average age of onset 
being 18 years, while depressive phases usually begin by age 21. 
 Higher incidences of comorbidities (accompanying conditions that include panic 
disorder, conduct disorder, substance abuse, suicidal behavior, and psychotic symptoms) 
are increased in individuals with BPD. Young patients are at higher risk for these 
complications.  BPD is often more severe in children than in adult patients, with a higher 
risk of mixed mania, multiple and frequent cycles, and a longer duration of illness 
without well periods.  
Symptoms of bipolar disorder in children are often confused with attention-deficit 
hyperactivity disorder (ADHD). Furthermore, the two conditions can coincide. In one 
study, 65% of adolescents with bipolar disorder met criteria for ADHD. Yet another 
study indicated that close to 25% of children diagnosed with ADHD either already had 
bipolar disorder or go on to develop it. The risk for both diagnoses is highest in 
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Caucasian males. In some cases, ADHD in children or adolescents may be a marker for 
an emerging bipolar disorder. 
Miscellaneous factors that may increase an individual’s risk for BPD include: 
change of seasons, socioeconomic status, and the loss of a parent. A higher incidence of 
bipolar disorder occurs in people who were born in the winter and in those who had 
experienced complications around the time of birth. The time of the year appears to play 
a role in the risk for specific episodes. Mania is more likely to occur in the summer and 
depressive episodes from October through May (which is different from seasonal 
affective disorder, a depressive disorder that only occurs in darker months). Bipolar 
disorder is more prevalent among people with a higher socioeconomic status. The rate of 
the disorder is estimated to be 10 to 20 times higher among people in the creative arts 
than in the general population. Thirdly, children who lose a parent early in life also 
appear to be more likely to develop bipolar disorder when they become adults. 
2.1.5 Molecular Genetics of BPD 
Family, twin, and adoption studies provide evidence for a heritable component to BPD11-
13. Family studies can determine if a condition occurs in multiple members of a family; 
however, it is difficult to separate genetic and environmental factors because families 
share common lifestyles. Twin and adoption studies are used in genetics to study 
individual differences by highlighting the role of environmental and genetic factors of a 
condition. Modern twin studies have shown that almost all traits are in part influenced by 
genetic differences, with some characteristics showing a strong influence (e.g. height), 
10 
 
others an intermediate level (e.g. IQ) and some more complex heritability, with evidence 
for different genes affecting different elements of the trait – such as BPD. Researchers 
found the heritability of BPD to be 80-90%13. Monozygotic and dizygotic twin 
concordance rates are 45-70% and 20%, respectively. These rates suggest that BPD is a 
multi-factorial inherited condition, affected by both genetics and environmental factors.  
An empiric risk is a risk estimate that is given for the chance of occurrence or 
recurrence of a particular condition in an individual based on the observation of other 
families with that condition. The Psychiatric Special Interest Group of the National 
Society of Genetic Counselors (NSGC) reviewed empiric risk literature for BPD in 
20063. The results are reported in Table 1.  
 
Table 1: Empiric Risks, reviewed by NSGC Psychiatric Genetics Special Interest Group3 
Relationship to affected individual Empiric Risk 
Any first degree relative 5-30% 
Parent 10% 
Sibling 13% 
Child (one parent affected) 15-30% 
Child (one parent affected) AND one sibling affected 20% 
Child (both parents affected) 50-60% 
Second degree relative 5% 
 
Bipolar disorder has been shown to have a strong genetic component, thus, the 
next step is to evaluate the disorder at the molecular level. Linkage analysis and genome-
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wide association studies have identified stretches of the genome with a likely 
susceptibility to causing BPD. Studies have reported significant chromosomal locations 
contributing to this susceptibility. The results are reported in Table 2. 
 
 
 
Table 2: Chromosomal Locations of Candidate Genes for BPD13-16 
Chromosomal Region Gene 
1q42 DISC1 
2p13-14 ASCT1 
6q22.3 DTNBP1 
8p12 NRG1 
13p; 13q ? 
22q12.3 TOM1/HMG2L1 
2.1.6 Direct to Consumer Testing 
Direct to consumer (DTC) marketing strategies have been implemented in the general 
population with regards to cancer genetics. Myriad Genetics© has implemented 
BRACAnalysis® to assesses a woman's risk of developing breast or ovarian cancer based 
on detection of mutations in the BRCA1 and BRCA2 genes. This test has become the 
standard of care in identification of individuals with hereditary breast and ovarian cancer. 
The biopharmaceutical company has also made advances in genetic testing for hereditary 
colorectal and endometrial cancer, pancreatic cancer, and melanoma17.  Companies such 
as 23andme© and Navigenics© offer comprehensive genetic testing and personal DNA 
analysis, in hopes of making personalized health care a reality for consumers. Currently, 
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such companies do not offer genetic testing for psychiatric disorders because recent 
research into the genetic risk markers has yielded inconsistent results.   
Difficulty arises in researchers’ ability to apply DTC to mental health genetics. 
Progress is being made to remove the stigma of mental illness in mental health 
disorders. Stigma, by definition, is a mark of disgrace or shame. Stigma has four 
components: labeling someone with a condition, stereotyping people who have that 
condition, creating a division — a superior "us" group and a devalued "them" group, 
resulting in loss of status in the community, and discriminating against someone on the 
basis of their label18; 19.  
For individuals with a mental illness, the consequences of stigma can be 
devastating — in some cases, worse than the illness itself. Some of the harmful effects 
of stigma include: trying to pretend nothing is wrong, refusal to seek treatment, rejection 
by family and friends, work problems or discrimination, being subjected to physical 
violence or harassment, or inadequate health insurance coverage of mental illnesses.  
Incorporating results from studies like this will enable public health professions to create 
a DTC marketing plan that is culturally sensitive and responsive to the needs of families 
with bipolar disorder20.  
Concerns arise when creating a DTC marketing plan, for any patient population. It 
will be important to provide accurate and proper informed consent for all consumers of 
DTC testing services, so they understand what results and interpretation are possible from 
testing. Currently, there is little governmental regulation for DTC testing and in fact, for 
many types of genetic tests. There are also concerns related to interpretation of results for 
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genetic tests in the BPD population. As we do not know a single gene cause for BPD, the 
interpretation of results must accurately reflect research of the genes being tested19; 20.  
2.1.7 Health Belief Model 
The Health Belief Model (HBM) was initially developed in the 1950’s by a group of 
social psychologists at the U.S. Public Health Service in an effort to explain the 
widespread failure of people to participate in programs to prevent or to detect disease. 
Later, the model was extended to apply to people’s responses to symptoms and to their 
behavior in response to diagnosed illness and compliance with medical regimens. Health 
screening behavior was determined to be driven by a combination of: 1) the individual’s 
perceived susceptibility to the condition, 2) the individual’s perceived seriousness of the 
condition, 3) the individual’s perceived benefit of the specific behavior, and 4) the 
individual’ perceived barriers to the behavior21 (Table 3). Variables and descriptions 
which are in bold and italics were applied to the project. HBM statements regarding BPD 
are located in Table 4 below.  
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Table 3: Health Belief Model Components 
Variable Description 
Perceived threat   
Perceived severity 
Feelings concerning the seriousness of developing a condition or leaving it
untreated (medical and social consequences) 
Perceived susceptibility Subjective perception of risk 
Perceived benefits The believed effectiveness of strategies used to reduce the burden of disease 
Perceived barriers 
Negative consequences that may occur if a particular health action is taken
(physical, psychological, or financial) 
Cues to action Bodily or environmental events that motivate an individual to take action 
Other variables Indirect effects of sociopsychological, demographic, and structural factors 
Self-efficacy The individual's belief that they can successfully execute the behavior 
 
Use of the Health Belief Model has been successful in assessing and motivating 
health belief change among African Americans in regards to genetic information and 
utilization of health care resources for sickle cell patients22. The HBM has been used in 
the assessment of health care facilities by sickle cell patients, suggesting the health 
beliefs pose modifiable psychosocial variables that could be used in development of 
interventions to reduce health care costs and provide additional education23. 
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Table 4: Health Belief Model Statements 
Severity 
Bipolar disorder is a serious disease. 
Having a child with bipolar disorder would be very scary.
My life would change if my child had bipolar disorder. 
 
Benefit 
It is useful to know if I have genes that make bipolar 
disorder more likely. 
It is useful to know if my partner has genes that make 
bipolar disorder more likely. 
Knowing the risk of having a child with bipolar disorder 
would change my plans about a future pregnancy. 
 
Susceptibility Barriers 
My children are at risk for bipolar disorder. Genetic testing for bipolar disorder is 
painful and difficult. 
Bipolar disorder could happen in my family. My partner would be hard to convince to 
have genetic testing. 
My partner may be a carrier of genes for
bipolar disorder. 
I would not want to pay for genetic 
testing. 
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3.0  MATERIALS AND METHODS 
3.1 DESIGN AND RATIONALE 
 
The overall goal of this project was to learn more about the needs of the US population 
diagnosed with BPD, anticipating that the demand for genetic counseling services for 
psychiatric disorders will increase in the future. Components of this study, including the 
knowledge and health belief surveys, were given to the participants in the US as part of 
the genetic counseling component. A study being conducted in India by Dr. Bhatia titled, 
“Neurological Endophenotypes in Psychiatric Genetic Research in India “ is collecting 
similar data and she shared her unpublished data so that comparative analyses could be 
made.  This comparison helps to elucidate whether the needs of both groups of 
participants are similar.  Data was collected from Indian participants by Dr. Bhatia and 
IRB-equivalent approval was obtained from Indian Council for Medical Research. 
Particularly of interest, the results of this study will be compared to the results in India to 
determine whether the needs and findings differ for the two patient populations24.  
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3.2 PARTICIPANTS 
Participants were recruited through public notification. A flyer was approved by the 
University of Pittsburgh IRB (Appendix E). Initially participants were recruited through 
the University of Pittsburgh and Western Psychiatric Institute and Clinic (WPIC); 
however, the response was less than desired. Research participants came from many 
sources across Pennsylvania, and Ohio, from centers partnered with WPIC and the flyers 
posted at these sites and throughout the University of Pittsburgh. Informed consent was 
obtained from all participants by verbal telephone script (US) or personal interview 
(India)  
Study criteria included: (1) age 18 years or above and (2) self-reported diagnosis 
of bipolar disorder or first-degree relative of an individual with a self-reported diagnosis 
of bipolar disorder. The racial, ethnic, and gender characteristics of the proposed study 
population reflect the demographics of the regions from which participants were drawn 
(Pennsylvania and Ohio, India). No exclusion was made based on race, ethnicity or 
gender. 
3.3 EXPERIMENTAL DESIGN 
The University of Pittsburgh Institutional Review Board (IRB) under IRB number 
0610128 in 2007-2009 (Appendix A) approved the experimental design for this study. An 
anonymous survey (Appendix C) was administered to each participant after verbal 
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informed consent (Appendix B) was given and documented. All contact with participants 
was over the telephone in the US and by personal interview in India. Research in India 
was a duplicated study.  
The survey was designed to measure familiarity with, and interest in, genetic 
counseling, knowledge of bipolar disorder, and health beliefs. The survey also 
ascertained demographic information and a brief psychiatric history. Knowledge of BPD 
was assessed using eight multiple-choice questions. The knowledge survey was modeled 
after a survey administered to school-age children and women of childbearing age to 
assess knowledge of sickle cell disorder. The health belief survey was modeled after a 
survey administered to women of childbearing age to assess health beliefs regarding 
sickle cell disease and sickle cell trait22.  Both the knowledge and health belief surveys 
were adjusted to apply to bipolar disorder for the study “Neurological Endophenotypes in 
Psychiatric Genetic Research in India”. The health belief survey used a five-point scale 
response system to assess perceived susceptibility, perceived seriousness, perceived 
benefit of testing, and perceived barriers to testing. A score of one corresponded to 
“strongly disagree” and a score of five corresponded with “strongly agree” as 
recommended by Champion21. The final set of questions was a set of five open-ended 
questions encouraging a discussion of the causes of bipolar disorder and the likelihood 
that there is a genetic component.  
Every other individual who completed the survey was offered participation in a 
brief educational session followed by an identical survey. The rationale behind this 
approach was that the first data set provides information on the patient population among 
the general population. The second data set would allow comparative analysis of the data 
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to see if knowledge, health beliefs, or opinions changed after the educational 
intervention.  
The educational session was a brief semi-structured discussion of genetic 
counseling, genetics, multifactorial inheritance, empiric risk for bipolar disorder, and 
general information about BPD.  
Telephone interviews were selected as the data collection technique because it 
allowed inclusion of participants who would not have otherwise been able to attend a 
face-to-face interview or focus group (e.g. those living in rural areas or living a great 
distance away). An additional benefit of this method is that some participants may 
perceive a greater degree of anonymity, thus increasing the validity of their responses25.  
Alternatives to the telephone interviews in the US would include face-to-face 
interviews, which would have allowed for observation of non-verbal cues and responses 
and may have built more trust with the interviewer.  
The Indian participants are required to have face-to-face interviews either at home 
or at the RML hospital. Telephone access is often limited in India, especially in the 
population served by RML Hospital. 
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3.4 DATA ANALYSIS 
3.4.1 Quantitative Analysis 
Data from affected individuals and first-degree relatives were analyzed to determine if 
there was a significant difference in knowledge, health beliefs, and acceptance of genetic 
counseling for psychiatric disorders between the US and Indian populations.. Answers to 
the knowledge questions were coded into variables, with correct answers coded as one 
and incorrect answers coded as zero. The maximum possible score for knowledge 
questions of BPD was eight. On the five-point scale, the population mean for perceived 
severity of BPD, susceptibility, benefits of testing, and perceived barriers to testing were 
calculated, including a score for each component and a cumulative score for each 
category. Values were categorized as low (0-3.0), moderate (3-4) or high (4-5) risk. 
Statistical significance was measured for each score, involving a 95% confidence 
interval. The difference between means was assessed using a t-score and p-values were 
documented. P-values less than 0.05 were considered statistically significant.  
3.4.2 Analysis of Responses to Open-Ended Questions 
Answers to the open-ended questions were analyzed to identify similarities and 
differences among responses. The goal was to find themes and differences in responses to 
the questions. Each individual’s answer to a question was compared to all other answers 
to that question, and themes were identified and described. A theme or pattern in answers 
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can be defined as a common topic, view or feeling. The themes generated from the open-
ended questions for this study were compared to the themes found in the semi-structured 
interviews conducted in India.  This comparison allows similarities and differences 
between the two populations to be described. 
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4.0  RESULTS 
4.1 DEMOGRAPHICS 
To date, 31 individuals have participated in this US study. The population surveyed was 
primarily over the age of 45 (48%), single (54%) and had no children (35%). The average years 
of schooling for participants were 11 years ± 3.40 years. To date the participant population is 
73% female and 27% male.  
From the unpublished data shared by Dr. Bhatia, 31 individuals have participated in the 
Indian study. The population surveyed was primarily over the age of 30, married (68%) and had 
no children (35%). The average years of schooling for participants were 14 years ± 3 years.  
         
 
Figure 1: Marital Status of Survey Participants, Lt: US, Rt: India 
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Figure 2: Age Distribution of Survey Participants, Lt: US, Rt: India 
 
 
 
 
      
Figure 3: Number of Children of Survey Participants, Lt: US, Rt:  India 
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4.2 SPECIFIC AIM 1 
Thirty-one individuals diagnosed with BPD have been surveyed in Pittsburgh. The cumulative 
perceived severity of BPD was high at 4.35 (±0.86), the cumulative perceived susceptibility to 
BPD was high at 3.90 (±1.06), the cumulative perceived benefit to genetic information was 
moderate at 3.82 (±0.82), and the cumulative perceived barriers to genetic testing were low at 
2.60 (±1.07) (Tables 5-8).  
Thirty-one individuals diagnosed with BPD have been interviewed in India. The 
cumulative perceived severity of BPD was moderate to high at 3.34±1.72, the cumulative 
perceived susceptibility to BPD was low at 2.60 ±1.59, the cumulative perceived benefit to 
genetic information was low at 2.60±1.69, and the cumulative perceived barriers to genetic 
testing were moderate to high at 3.38 ±3.15 (Tables 5-8).  
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Table 5: Summary of Health Beliefs: Severity 
Severity India Mean±SD US Mean±SD t(p value) 
Bipolar disorder is a serious disease. 4.44 ±1.04 4.77±0.80 1.35(NS) 
Having a child with bipolar disorder would
be very scary. 3.60±1.63 4.23±1.14 1.68(NS) 
My life would change if my child had
bipolar disorder. 4.23±1.1.33 4.06±1.41 -0.45(NS) 
*Severity Cumulative 3.34±1.72 4.35±0.86 2.91(0.005) 
 
The US cumulative perceived severity of BPD was high at 4.35 (±0.86) and moderate to 
high at 3.34±1.72 in the Indian population. Individual questions did not show statistical 
significance (Table 5). 
 
Table 6: Summary of Health Beliefs: Susceptibility 
Susceptibility India Mean±SD US Mean±SD t(p value) 
My children are at risk for bipolar
disorder. ** p<0.05 3.15 ±1.76 4.00 ±1.29 2.09(0.04) 
Bipolar disorder could happen in my
family. **p<0.05 3.28 ±1.59 4.48 ±0.81 3.66(0.001) 
My partner may be a carrier of genes for
bipolar disorder.  3.00 ±1.62 3.33 ±1.65 0.76(0.45) 
*Susceptibility Cumulative 2.60 ±1.59 3.90 ±1.06 3.78(<0.001) 
 
The US cumulative perceived susceptibility to BPD was high at 3.90 (±1.06), and was 
low at 2.60 ±1.59 in the Indian population. Also noted of significance are two individual 
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statements highlighted in pink. The first statement was ‘my children are at risk for bipolar 
disorder; the second statement was ‘bipolar disorder may happen in my family’ (Table 6). 
 
Table 7: Summary of Health Beliefs: Benefit 
Benefit India Mean±SD US Mean±SD t(p value) 
It is useful to know if I have genes that
make bipolar disorder more likely. 3.56±1.68 4.65±0.71 3.25(0.002) 
It is useful to know if my partner has genes
that make bipolar disorder more likely. 3.32±1.73 4.47±1.04 2.98(0.004) 
Knowing the risk of having a child with
Bipolar disorder would change my plans
about a future pregnancy. 3.48±1.73 2.48±1.41 -2.33(0.02) 
*Benefit Cumulative 2.60±1.69 3.82±0.82 3.58(0.001) 
 
The US cumulative perceived benefit to genetic information was moderate at 3.82 
(±0.82), and was low at 2.60±1.69 in the Indian population. All three statements yielded results 
of statistical significance (Table 7). 
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Table 8: Summary of Health Beliefs: Barriers 
Barriers India Mean±SD US Mean±SD t(p value) 
Genetic testing for Bipolar disorder is
painful and difficult. 2.61 ±1.69 1.97 ±1.33 -1.556(NS) 
My partner would be hard to convince to
have genetic testing. 2.83 ±1.61 2.79 ±1.72 -0.07(NS) 
I would not want to pay for genetic testing. 2.90 ±1.92 3.23 ±1.54 0.667(NS) 
*Barriers Cumulative 3.38 ±3.15 2.60 ±1.07 -1.29(NS) 
 
The US cumulative perceived barriers to genetic testing were low at 2.60 (±1.07), and 
moderate to high at 3.38 ±3.15 in the Indian population. None of the statements or cumulative 
results was of statistical significance (Table 8).  
Data show that the knowledge of BPD in US individuals is high, with an average score of 
6.19 correct (±1.51) out of a possible 8 questions. The lowest score to date is 2 correct and the 
highest score is 8 correct. Data are insufficient to determine if there is a significant difference in 
knowledge of BPD or in acceptance of genetic counseling before and after the education session. 
Many individuals chose not to participate in the education session after the preliminary interview 
for unknown reasons. Data show that the knowledge of BPD in Indian participants is low, with 
an average score of 2.68 correct (±1.62) out of a possible 8 questions. After the educational 
session given to Indian participants, data showed Indians had less knowledge about testing and 
counseling prior to learning the new information than after.  
Analyzing the data in correlation with demographic factors showed that participants in 
the Indian population have little knowledge about their diagnosis of BPD. This may be culturally 
related, as mental illness may not be as accepted in India when compared to the United States24; 
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28. Research conducted in India about the stigma of mental illness revealed that depressive 
symptoms were perceived as socially disadvantageous as these may affect marriage, social 
status, and employment28. 
Answers to the open-ended questions were analyzed to identify themes. Analysis 
revealed four common responses to the first question, “when you first heard about mental illness 
in your family, what did you think caused it?” (Table 9) Most participants in the US attributed 
their diagnosis of BPD as a combination of factors: life-triggering event and genetic causes. On 
the other hand, Indian participants attributed their diagnosis to bad eating habits, a chemical 
imbalance and stress (Table 10). 
 
Table 9: Common Responses to Open-ended Question 1, US Data. 
When you first heard about mental illness in your family, what do you think caused 
it? 
"An imbalance of chemicals in my brain."  
"In my family, I would say events, life-changing events happened." 
"Well, I guess I had felt that mine was related to stress and, like, maybe a 
predisposition to feel depressed and melancholy in certain situations.  When I was 
under a lot of stress I began to experience more symptoms, so like, when I had some 
breakdowns and was hospitalized I relate them to stressful circumstances.  But, I 
feel like I had a predisposition." 
"My life was a triggering event - a combination of factors. It is genetic made worse 
by people not understanding. Self medication is destructive. I think it is caused by 
genetics. The degree depends on the environment." 
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Table 10: Common Responses to Open-ended Question 1, India Data. 
When you first heard about mental illness in your family, what do you think caused 
it? 
"When I came to know about myself that, I personally was at the verge of (being in 
the grip of mental illness), I was completely shocked & really it was totally 
surprising. " 
"How did it happened to me and how will I maintain my employment"  
 
4.3 SPECIFIC AIM 2 
The second specific aim was designed to assess participants’ knowledge of genetic counseling, 
as well as the interest and acceptance of genetic counseling sessions and the possibility of 
genetic testing in the future. 
Thirty-one US participants with a diagnosis or family history of BPD have been 
surveyed. Data show that the knowledge of genetic counseling is low, with only 30% of 
participants stating that they have heard of genetic counseling or know what it is, prior to an 
education session. Twelve of 31 individuals (39%) stated that they did not know if genetic 
counseling would be useful to them. Results from Indian participants were not available as of 
March 2009. 
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5.0  DISCUSSION 
This study examined the health beliefs, level of knowledge and acceptance of genetic counseling 
in individuals with BPD and their first-degree relatives. The demand for genetic counseling is 
growing in the medical profession, specifically in the area of psychiatric genetics29. As medical 
professionals it is important to determine the needs of this patient population and offer new 
services accordingly.  The study was designed to look at whether an educational session can 
improve or change acceptance of genetic counseling or health beliefs. It is important to provide 
evidence that education is a good intervention to offer more information to this patient 
population, with goals of furthering psychiatric genetic counseling. Determining possible 
changes in acceptance of genetic counseling after the education session has the potential to show 
that interest in genetic counseling services increases with just a short discussion of the 
multifactorial pattern of inheritance and current research regarding genetic influences of BPD.   
5.1 SPECIFIC AIM 1 
The first aim was to determine the current health beliefs of those who have been 
diagnosed or who have a family history of bipolar disorder (BPD) with regard to course, 
treatment, and genetic information. It was hypothesized that participants would have a low level 
  
 
31
of knowledge of BPD, and this was, in fact, not supported by the data. Data show that 
participants have high background knowledge of their condition. In addition, it was hypothesized 
that participants would have a high level of perceived severity, a high level of perceived 
susceptibility, a moderate level of perceived benefit to testing and a low level of perceived 
barriers to testing. Data reveal that participants in the US had perceptions of high severity, 
susceptibility and knowledge of BPD, perceptions of moderate benefit to testing, and perceptions 
to barriers of testing. High severity of BPD indicates that many participants felt that BPD is a 
serious disease and having a child with BPD would impact their life in significant ways. High 
perceived susceptibility indicates that there is a concern of risk to other family members. Of 
note, two of the questions that asked about susceptibility had statistical significance with p-
values <0.05. Moderate benefit to genetic information indicates that participants are interested in 
genetic information. A low level of concern regarding barriers to genetic testing indicates US 
participants are not worried about the testing procedures itself. Future studies aimed at educating 
individuals with BPD about severity and susceptibility could potentially ease anxiety about their 
condition. 
In comparing the data collected from Indian participants, data reveal perceptions of 
moderate severity, and barriers to testing, and perceptions of low susceptibility, benefit to genetic 
information and knowledge of BPD.  These results differ from the US participants’ perceptions 
and may be due to different perceptions of mental illness in the Indian population24; 28; 30. Low 
susceptibility indicates that there is the notion that there is not an increased risk to other family 
members. Low concern regarding benefit of genetic information indicates individuals are not 
interested in receiving genetic information. These participants are concerned about the 
seriousness of the disorder, but do not believe BPD has a genetic component. Moderate severity 
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of BPD indicates that many participants felt that BPD is a serious disease and having a child with 
BPD would impact their life in significant ways. Moderate barriers to genetic testing indicate 
that participants have an increased level of concern regarding testing procedures.  
The analysis of the open-ended questions provides valuable information for future studies 
regarding BPD genetics. In a more detailed examination in comparing answers of the knowledge 
questions to views stated in the open-ended questions, it was striking that some individuals chose 
answers based on a genetic component to BPD, yet stated that BPD is mainly environmental in 
the open-ended questions.  Those same participants then stated there is a high probability of 
passing the condition onto their children. If individuals have a strong belief about the cause of 
their disorder (i.e. environmental vs. genetic), it may be a barrier to accurately assessing a family 
history in a genetic counseling session. This is an important theme to examine, in the future, by 
creating an educational support group for members of the BPD community and their family 
members to learn more about their condition and for genetic counselors to record an accurate 
family history for better risk assessment. 
5.2 SPECIFIC AIM 2 
The second specific aim of the study was to assess participants’ knowledge of genetic 
counseling, and to assess acceptance of and interest in genetic counseling services and the future 
of genetic testing.  
Identifying the status of knowledge and acceptance of genetic counseling will determine 
areas of education that might lead to increase knowledge and acceptance. Data show moderate 
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benefit of genetic information, which indicates that most individuals diagnosed or with a family 
history of BPD would like to know if they or their partners have genes that make bipolar disorder 
more likely to occur. In looking at US data on susceptibility, data from one statement, “My 
children are at risk for bipolar disorder” has a statistical significant score of 3.9 (±1.06) out of a 
possible 5 (using a t-value of 3.78 and a p-value <0.01). Data on the question, “Knowing the risk 
of having a child with Bipolar disorder would change my plans about a future pregnancy” has a 
statistical significant score of 2.48 (±1.42) out of possible 5 (using a t-value of 2.33 and a p-value 
of 0.02), indicating that genetic information may not be used for reproductive purposes. In 
looking at the Indian data on susceptibility, the data suggest these participants are not as worried 
about an inheritable component for BPD. Indian participants felt BPD is less likely to occur in 
the family, less likely to have children with BPD, and not as concerned about their partner’s 
carrier status as compared to the US population. 
The US cumulative perceived barriers to testing were low. However, on average, 
participants disagreed with the statement that genetic testing is painful and difficult with a score 
of 1.97 (±1.33).  The strongest perceived barrier included convincing their partners to have 
genetic testing. The Indian cumulative perceived barriers to testing were moderate to high. On 
average, participants felt that genetic testing could be painful and difficult, and would not be 
interested in paying for genetic testing. Conclusions suggest that participants do not have 
knowledge of how genetic testing is completed, the cost of testing, or possible testing 
interpretations.  
Studying the correlations between demographic factors and knowledge, health beliefs, 
and acceptance of genetic counseling will aid in properly serving this patient population and 
giving clients the information they are seeking. Additional analysis between knowledge of BPD 
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and health beliefs may show some affect on severity, susceptibility, benefits and barriers to 
genetics testing for BPD. 
Data bias can not be eliminated from the individuals surveyed because attitudes of the 
populations studied have not been altered. Attitudes influencing results include: religious 
preference, political issues, tolerance of mental health, and general cultural beliefs. Bias that has 
been eliminated includes: participants were recruited for this study only. Participants gathered in 
the beginning of the study (2007) were gathered through another study of BPD in Pittsburgh. The 
original data could be skewed, knowing those individuals would have additional exposure to 
learning more about BPD and genetics because they were apart of a BPD genetics support group.  
One final limitation of the study: all contact with US participants was over the telephone, 
including a self-report of diagnosis. Telephone interviews do not allow for patient/counselor 
interaction and may affect any rapport that could be established between individuals facilitating 
communication. In regards to the education session, it was modeled after a genetic counseling 
session in which the interviewer is trained when trying to detect non-verbal cues to assess how 
much of the material the patient understood.  
Genetic counselors can help patients understand the complexities of genetic information 
and testing by providing insights into a test’s benefits, risks, and implications before an 
individual takes the test. Counselors also help patients interpret the results and consider 
management steps, if necessary. Finally, they may help individuals deal with their genetic risk, 
something that may be necessary whether the testing outcome is positive or negative, since the 
test “may change long-held beliefs about disease risk.” This type of work could be problematic if 
completed over the telephone, because counselors often use additional visual materials to aid 
individuals who adapt best to visual learning. For example, genetic counselors often use visual 
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aids to assist in the learning process of genetic information and genetic testing. Some individuals 
may learn more easily when presented with information in a visual form.   
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6.0  CONCLUSION 
This study was successful in eliciting health beliefs and knowledge from individuals diagnosed 
with bipolar disorder. The information gained from the study could be used to develop an 
educational model for individuals with BPD and their families.   
Characterization of the current state of health beliefs of the BPD population is still in 
progress, as participant recruitment continues. According to the data at this point, the results 
show high level of severity, susceptibility and knowledge of BPD, moderate benefit of genetic 
information and low level of concern to barriers of genetic testing in the US population. Results 
of the Indian population show moderate level of concern to severity and barriers of genetic 
information, and low levels of concern to susceptibility, benefit of genetic information and 
knowledge of BPD. Similarity among both countries is found in the level of severity of BPD; 
both countries believe it is a severe condition. Differences between both countries can be seen in 
regards to benefit to genetic information: US participants want to know the information, whereas 
Indian participants do not feel a need for the information because they believe BPD is not 
genetic. Differences are also noted with regards to susceptibility to BPD: US participants know 
their children and family members are at risk for BPD, while the Indian participants do not feel 
other family members are at-risk to develop BPD. Finally, the US and Indian participants differ 
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when talking about barriers to genetic testing: US participants are not as concerned about testing 
procedures, while Indian participants have a high level of concern. 
Aside from the results of the Health Belief Model, researchers gained insight into other 
areas of BPD. Participants in both countries had different viewpoints in regards to BPD 
predisposition: Americans felt there is a mix of genetic and environmental factors, while Indians 
felt it was caused by stress, environmental factors or poor eating habits. This difference may be a 
result of how BPD is discussed in these countries. BPD has a stigma in both countries, but the 
stigma is much worse for Indians. Indian participants were most concerned how BPD would 
affect their employment, marital and social status.  
Much was learned throughout the process of implementing this study. First of all, the 
success of this project would only occur with an open and active participation of all parties 
involved. Without the support of the Graduate School of Public Health (GSPH) and Western 
Psychiatric Institute and Clinic (WPIC), participation would have been limited. This may have 
also added some limitations to our study by supplying participants who are already in a 
heightened state of awareness of the importance of knowledge of BPD. These participants have 
actively pursued to learn more information about their condition and so may already be open to 
health care information and the future of genetic testing.  
Our study hopes to continue gathering participants and assessing their beliefs about BPD 
as they consider the value of knowledge and genetic counseling for mental health disorders. As 
the data from India highlights, future developments of the study and educational interventions 
that are developed based on the results should take into account unique beliefs and cultural 
aspects of the community at risk.  Recognizing the different ways in which cultural background 
can influence perceptions is important in addressing the needs of a particular community.  . 
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Focus can then be directed to providing more information regarding susceptibility, testing, and 
severity of BPD, as well as benefits and limitations to psychiatric genetic counseling in a 
culturally sensitive manner.  
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APPENDIX A: IRB REVIEW LETTERS 
INSTITUTIONAL REVIEW BOARD (IRB) REVIEW LETTERS 
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APPENDIX B: CONSENT FORM 
CONSENT FORM 
_________________________________________ 
Participant’s Name 
 
“I certify that I have explained the nature and purpose of this research study to the above-
named individual(s), and I have discussed the potential benefits and possible risks of study 
participation. Any questions the individual(s) have about this study have been answered, and we 
will always be available to address future questions, concerns or complaints as they arise. I 
further certify that no research component of this protocol was begun until after this consent 
form was signed.” 
__________________________________    ___________ 
Printed name of Person Obtaining Consent    Role in Study 
__________________________________    ___________ 
Signature of Person Obtaining Consent    Date 
 
After completion of the informed consent, the survey will be administered. At the conclusion of 
the survey, every other participant will be asked if they would like to participate in the individual 
educational session, using the following script: 
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 “As I mentioned earlier, some people who complete the first interview are asked to 
participate in the second phase of the study. This can be done immediately or at a time 
convenient for you. This part of the study, also over the telephone, will include an educational 
interview about bipolar disorder, family history, the science behind inheritance and recurrence in 
a family, and a discussion about genetic testing and its impact. This session will also conclude 
with an interview including multiple choice and opened ended questions. Participants completing 
this phase and follow-up survey will be given an additional $25 Giant Eagle gift card. Your 
participation in this part of the study is completely voluntary. You may refuse to take part in it, 
or you may stop participating at any time. Do you have any questions? Do you think you might 
be interested in participating in that study?” 
 
If yes, begin the individual educational session. If no, thank you for participating in our study. 
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APPENDIX C: SURVEY 
SURVEY 
C.1 DEMOGRAPHIC AND PSYCHIATRIC HISTORY QUESTIONAIRRE 
1. How old are you? 
2. What is your marital status? 
 
• Single 
• Married 
• Divorced 
• Widowed 
 
3. How many children do you have? 
 
• 0 
• 1 
• 2 
• 3 
• 4 
• 5+ 
 
 
4. Do you live with your partner? 
 
• Yes  
• No 
• I don’t have a partner 
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5. What is the highest level of education you finished? 
 
• Some high school 
• High school graduate 
• Some college 
• College graduate 
• Graduate/Doctoral/Professional School 
 
 
6. Do you have, or have you had, bipolar disorder? 
 
• Yes 
• No 
 
7. Do you have a relative who has been diagnosed with Bipolar Disorder? 
 
• Yes 
• No 
 
7b. If yes, which family member or family members have bipolar disorder? (all that 
apply) 
 
• Myself 
• Mother 
• Father 
• Child 
• Adopted child 
• Brother 
• Sister 
• Grandparent 
• Aunt/Uncle (blood relation) 
• Cousin 
• Other (please specify) 
 
 
 
Follow-up questions for “affected subject with no affected first-degree relatives” and 
“affected subject with one or more affected first-degree relatives”: 
 
 
1. How long ago were you diagnosed? 
 
• In the last 6 months 
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• 6-12 months ago 
• 1-2 years 
• 3-5 years 
• 5+ years 
• Other 
 
 
 
2. When did you last actively have symptoms? 
• Currently in an active phase 
• In the last 6 months 
• 6-12 months ago 
• 1-2 years ago 
• 3-5 years ago 
• 5+ years 
• Other  
 
 
3. Are you currently being treated for Bipolar Disorder? 
• Yes  
• No 
3b. If yes, what type of treatment? (all that apply) 
• Taking medication 
• In day therapy 
• In residential therapy (hospital) 
• Other  
 
 
4. Do you have any other psychiatric diagnoses? 
• Yes 
• No 
• Do not know 
 
4b. If yes, what is the diagnosis? 
• Personality disorder 
• Manic depression 
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• Depression 
• Schizophrenia or schizoaffective disorder 
• Other 
• Do not know 
 
C.2 GENETIC COUNSELING QUESTIONAIRRE 
13. Have you heard of genetic counseling? 
• Yes 
• No 
 
14. Do you know what genetic counseling is? 
• Yes  
• No 
 
15. Have you ever had genetic counseling? 
• Yes 
• No 
 
16. If yes, was it due to a family or personal history of bipolar disorder? 
• Yes 
• No 
 
17. Do you think genetic counseling would be useful to you? 
• Yes 
• No 
 
Comments: 
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C.3 KNOWLEDGE QUESTIONAIRRE 
Following are some questions about bipolar disorder. I will read each question to you, along with 
five possible answers. Please select the one best answer for each question. 
 
1. Bipolar disorder is caused by 
a. Dirty needles 
b. A virus 
c.  Inheriting genes from parents 
d. The exact cause is unknown currently 
e. none of the above 
 
2. How many genes must someone inherit to have Bipolar disorder? 
 a. zero, it is not caused by genes 
 b. one from their mom 
 c. two, one from their mom, and one from their dad 
 d. the number of genes is not presently known 
 e. none of the above 
 
3. Bipolar disorder can cause 
 a. euphoria, feeling ‘high’ 
 b. racing thoughts, talkativeness 
 c. drug or alcohol use 
 d. inability to concentrate well 
 e. all of the above 
 
4. Bipolar disorder is most likely caused by 
 a. genes 
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 b. the environment such as a major life event 
 c. a combination of genes and environment such as a major life event 
 d. radiation 
 e. none of the above 
 
5. Bipolar disorder is a serious condition that causes shifts in 
 a. mood 
 b. energy 
 c. functioning 
 d. all of the above 
 e. none of the above 
 
6. Bipolar disorder is present 
 a. more in poor people 
 b. more in rich people 
 c. same across all ethnic and economic group 
 d. more in some ethnic groups 
 e. more in some regions 
 
7. Bipolar disorder is treated by 
 a. medications known as mood stabilizers 
 b. liver transplant 
 c. rest 
 d. blood transfusions 
 e. none of the above 
 
8. How can you tell if someone carries genes for Bipolar disorder? 
 a. they look sick 
 b. they will eventually have Bipolar disorder 
 c. with a simple blood test 
 d. there is no way of knowing 
 e. none of the above 
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C.4 HEALTH BELIEF ASSESSEMENT 
Please rate your level of agreement with each of the following statements on a 5-point scale 
where 1 means “strongly disagree” and 5 means “strongly agree”.  
 
C.4.1 Severity 
1. Bipolar disorder is a serious disease. 
Strongly disagree 1 2 3 4 5 Strongly Agree 
2. Having a child with bipolar disorder would be very scary. 
Strongly disagree 1 2 3 4 5 Strongly Agree 
3. My life would change if my child had bipolar disorder. 
Strongly disagree 1 2 3 4 5 Strongly Agree 
C.4.2 Susceptibility 
4. My children are at risk for bipolar disorder. 
Strongly disagree 1 2 3 4 5 Strongly Agree 
5. Bipolar disorder could happen in my family. 
Strongly disagree 1 2 3 4 5 Strongly Agree 
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6. My partner may be a carrier of genes for bipolar disorder. 
Strongly disagree 1 2 3 4 5 Strongly Agree 
C.4.3 Benefit 
7. It is useful to know if I have genes that make bipolar disorder more likely. 
Strongly disagree 1 2 3 4 5 Strongly Agree 
8. It is useful to know if my partner has genes that make bipolar disorder more likely. 
Strongly disagree 1 2 3 4 5 Strongly Agree 
9. Knowing the risk of having a child with bipolar disorder would change my plans about a 
future pregnancy. 
Strongly disagree 1 2 3 4 5 Strongly Agree 
C.4.4 Barriers 
10. Genetic testing for bipolar disorder is painful and difficult. 
Strongly disagree 1 2 3 4 5 Strongly Agree 
11. My partner would be hard to convince to have genetic testing. 
Strongly disagree 1 2 3 4 5 Strongly Agree 
12. I would not want to pay for genetic testing. 
Strongly disagree 1 2 3 4 5 Strongly Agree 
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C.4.5 Open-ended Questions 
13. When you first heard about mental illness in your family, what did you think caused it? How 
do you think it happened or occurred? 
 
14. When we say a condition might be inherited, what does that mean to you? 
15. How do you think a hereditary condition would affect your family now and in the future? 
16. Do you think bipolar condition is hereditary? 
If response is Yes and you have bipolar disorder – what do you think your risk is for 
passing it on to a child? 
 
If response is Yes and you do not have bipolar disorder – what do you think your risk is 
for developing the condition? 
 
17. Do you have any other comments you would like to share? 
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APPENDIX D: EDUCATIONAL SESSION OUTLINE 
EDUCATIONAL SESSION OUTLINE 
a) Contracting: In this education session we will discuss what is known and what is not known 
about the genetics and effects of bipolar disorder. Please feel free to ask any questions 
that you may have. This will be similar to a genetic counseling session. 
b) What is genetic counseling? 
i) Genetic counseling is a discussion of the genetic causes for a disorder, the chance that 
other family members will show signs and symptoms of the disorder, how the 
diagnosis may affect the family, and where people can go for more information. 
c) Genetic counseling usually involves a brief discussion of genetics. 
i) Genetics is the study of DNA. You may have heard of DNA before. DNA is like an 
instructional manual for the body. We each have our own, unique DNA code, but 
we also share some of that code with our family members. 
(1)We know that changes in the DNA can put people at risk for developing 
certain conditions. 
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(a) For bipolar disorder, the exact causes are not completely understood, 
but at present time it seems that both genetic and environmental 
factors may increase the risk for BPD. 
(b) The number and exact locations of the predisposing genes are not 
known. 
(c) If you have one first-degree relative with BPD, your risk of about 3-
15%, although some studies say the risk is as high as 24%. 
ii) At present, there is no way to tell if a person carries genes that make them more 
susceptible to BPD. You cannot tell by looking at someone, by a physical exam, 
or with genetic testing. 
d) What are the effects of BPD? 
 i) BPD can affect moods, energy levels and functioning. 
e) Who does BPD affect? 
i) BPD affects about 1% of the population. Current evidence suggests that it affects men 
and women equally, and the rate is equal across ethnic groups. 
f) Treatment 
i) Most individuals affected with BPD are treated with mood stabilizers. Sometimes 
antidepressants are also prescribed. Doctors work with their patients to find the 
best possible management. 
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APPENDIX E: RECRUITMENT FLYER 
RECRUITMENT FLYER 
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